View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Uncategorised
February 22, 2021

Coronavirus company news summary – Pfizer/BioNTech publishes data showing their Covid-19 vaccine can be stored at higher temperatures – J&J seek Covid-19 vaccine approval from the WHO

By Allie Nawrat

22 February 2021

Pfizer and BioNTech have submitted new data to the US Food and Drug Administration (FDA) that showed their Covid-19 vaccine was stable when stored between -25°C and -15°C (-13°F to 5°F), which is temperatures of pharmaceutical freezers. This data will be used to support a proposed update to the companies’ US emergency use authorisation (EUA) prescribing information to allow the vaccine to be stored at these temperatures for two weeks as an alternative to a ultra-low temperature freezer of -80°C.

Johnson & Johnson (J&J) has submitted an emergency use listing to the World Health Organization (WHO) for its single-dose Janssen Covid-19 vaccine candidate. The data package submitted includes  interim efficacy and safety results from a Phase III ENSEMBLE clinical trial. This means J&J has completed its rolling data submission to the WHO.

Chugai Pharmaceutical has concluded a license agreement with Roche to develop and market AT-527, a new oral drug for Covid-19, in Japan. Global Phase II clinical studies of AT-527 are currently ongoing in mild to moderate Covid-19 patients. AT-527 was created by Atea Pharmaceuticals in the US, but it is being jointly developed with Roche. As a result of this deal, Chugai now has exclusive rights to develop and market AT-527 in Japan.

According to Nikkei, Fujifilm Holdings will restart clinical trials of Avigan, its antiviral drug for treating Covid-19, in Japan. The drug’s approval was delayed because of inconclusive trial data, according to a Japanese health ministry panel in December 2020. The new study will involve approximately 270 patients and Fujifilm will seek approval again in October 2021.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology